Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 724-728, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, G. D.
Right arrow Articles by Frost, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, G. D.
Right arrow Articles by Frost, P.

Cell Proliferation in Human Basal Cell Carcinoma1

Gerald D. Weinstein and Phillip Frost

Department of Dermatology, University of Miami School of Medicine, Miami, Florida 33136

Information about cell proliferation kinetics in human cancers has been limited by the inaccessibility of most tumors. Basal cell carcinomas are very common, slowly growing, locally invasive tumors of skin that have been studied by autoradiographic techniques using tritiated thymidine in vivo. The reproductive cycle of the germinative cell population was analyzed. The DNA synthesis period was found to be 20 hr; the G1 period, 188 hr; the G2 period, 7 hr; the mitotic period, 1.5 hr; and the total germinative cycle, approximately 217 hr. These results indicate that there is more cell proliferation activity in a basal cell carcinoma than suggested by the clinically apparent slow growth of the tumor. Therapeutic aspects of basal cell carcinoma are discussed relating to chemotherapeutic drugs.

1 This investigation was supported by NIH Research Grants CA-10292 and AM-11559 and a grant from the John A. Hartford Foundation. The facilities of the General Clinical Research Center supported by NIH Grant FR 0261 were used.

Received 6/10/69. Accepted 8/11/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.